SAN FRANCISCO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- RPX Corporation (Nasdaq:RPXC), a leading provider of patent risk management solutions, today announced its financial results for the fourth quarter and year ended December 31, 2012.
Financial Highlights
- Revenue for the fourth quarter of fiscal 2012 totaled $51.6 million, up 22% from the prior year period
- Revenue for fiscal 2012 totaled $197.7 million, up 28% from fiscal 2011
- GAAP net income for the fourth quarter of fiscal 2012 was $10.1 million or $0.19 per pro forma diluted share[1]
- GAAP net income for fiscal 2012 was $39.0 million or $0.74 per pro forma diluted share[1]
- Non-GAAP net income for the fourth quarter of fiscal 2012 was $12.3 million or $0.24 per pro forma diluted share[1]
- Non-GAAP net income for fiscal 2012 was $47.1 million or $0.90 per pro forma diluted share[1]
"RPX reported a solid 2012, capped by a strong fourth quarter with progress in client growth, patent acquisition activity, and the roll out of our insurance service," said Chief Executive Officer John Amster. "These results affirm that our mission to help companies manage and reduce exposure to patent risk is being embraced by the market."
Summary Results
Revenue for the fourth quarter increased 22% to $51.6 million, compared to $42.4 million in the fourth quarter of 2011. For fiscal year 2012, revenue was $197.7 million, compared to revenue of $154.0 million for fiscal year 2011.
Net acquisition spend during the quarter totaled $23.2 million, and included seven new acquisitions of patent assets, in addition to the exercise of previously negotiated options to acquire licenses for new clients.
GAAP net income for the quarter was $10.1 million or $0.19 per diluted share, compared to $6.9 million or $0.13 per diluted share in the fourth quarter of 2011. Net income was $0.19 per pro forma diluted share[1] in the fourth quarter, compared to $0.13 per pro forma diluted share[1] in the fourth quarter of 2011. For fiscal 2012, GAAP net income was $39.0 million or $0.74 per diluted share, compared to $29.1 million or $0.57 per diluted share for fiscal 2011. Net income was $0.74 per pro forma diluted share[1], compared to $0.60 per pro forma diluted share[1] for fiscal 2011.
Non-GAAP net income for the quarter, which excludes stock-based compensation, the amortization of acquired intangibles and in 2011 it also excludes a payment in lieu of a contingent obligation (in each case, net of tax), was $12.3 million or $0.24 per pro forma diluted share[1], compared to $11.3 million or $0.22 per pro forma diluted share[1] in the fourth quarter of 2011. For fiscal 2012, Non-GAAP net income was $47.1 million or $0.90 per pro forma diluted share[1], compared to $37.1 million or $0.77 per pro forma diluted share[1] for fiscal 2011.
As of December 31, 2012, RPX had cash, cash equivalents and short-term investments of $199.7 million.
Business Outlook
This outlook reflects the Company's current and preliminary view and may be subject to change. Please see the paragraph regarding "Forward-Looking Statements" at the end of this news release.
The Company provided the following business outlook for the first quarter of fiscal 2013:
| Subscription revenue[2] | $52.8 - $53.3 million |
| Other revenue | $7.2 million |
| Total revenue | $60.0-- $60.5 million |
| Net income (non-GAAP) | $15.0 - $15.5 million |
| Effective tax rate (non-GAAP) | 37% |
| Pro forma weighted-average diluted shares outstanding | 52.5 million |
The Company provided the following business outlook for the full year 2013:
| Subscription revenue[2] | $215 - $225 million |
| Other revenue | $8 - $10 million |
| Total revenue | $223 - $235 million |
| Cost of revenue (non-GAAP) | $96 - $101 million |
| SG&A (non-GAAP) | $48-- $52 million |
| Net income (non-GAAP) | $47 - $52 million |
| Effective tax rate (non-GAAP) | 37% |
| Pro forma weighted-average diluted shares outstanding | 53.3 million |
| Net acquisition spend | $115 - $125 million |
The above outlook is forward-looking. Actual results may differ materially. Please refer to the information under the caption "Use of Non-GAAP Financial Information" below.
[1] Pro forma diluted shares computed to give effect to the shares of restricted stock outstanding as of the original date of issuance and the conversion of the Company's redeemable convertible preferred stock into common stock using the as-if converted method as though the conversion had occurred as of January 1, 2011 or the original issuance, if later.
[2] Subscription revenue is comprised of revenue generated from membership subscription services and premiums earned from insurance policies.
Change in CFO
Separately RPX announced that its Chief Financial Officer, Adam Spiegel, will be leaving the Company to explore earlier stage opportunities. He will be replaced by Ned Segal, an investment banker with Goldman Sachs & Co., and currently Head of Global Software Investment Banking and COO of Technology Banking. Mr. Segal will join RPX no later than June 1, 2013 and Mr. Spiegel will be leaving RPX on or before June 1, 2013.
Conference Call
RPX management will host a conference call and live webcast for analysts and investors at 2:00 p.m. PDT/5:00 p.m. EDT on February 12, 2013. Parties in the United States and Canada can access the call by dialing 1-877-941-9205, using conference code 4590942. International parties can access the call by dialing 1-480-629-9645, using conference code 4590942.
RPX will offer a live webcast of the conference call which can be accessed from the "Investor Relations" section of the Company's website at http://ir.rpxcorp.com. An audio replay of the conference call will also be available approximately two hours after the call and will be available for 30 days. To hear the replay, parties in the United States and Canada should call 1-800-406-7325 and enter conference code 4590942. International parties should call 1-303-590-3030 and enter conference code 4590942.
About RPX Corporation
RPX Corporation (Nasdaq:RPXC) is a leading provider of patent risk solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services. Since its founding in 2008, RPX has introduced efficiency to the patent market by providing a rational alternative to litigation. The San Francisco-based company's pioneering approach combines principal capital, deep patent expertise, and client contributions to generate enhanced patent buying power. By acquiring patents, RPX helps to mitigate and manage patent risk for its growing client network.
Use of Non-GAAP Financial Information
This news release dated February 12, 2013 contains non-GAAP financial measures. Tables are provided in this news release that reconcile the non-GAAP financial measures to the most directly comparable financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures include non-GAAP cost of revenue, non-GAAP selling, general and administrative expenses, non-GAAP net income, and non-GAAP net income per share.
To supplement the Company's condensed consolidated financial statements presented on a GAAP basis, management believes that these non-GAAP measures provide useful information about the Company's core operating results and thus are appropriate to enhance the overall understanding of the Company's past financial performance and its prospects for the future. Management is excluding from its non-GAAP operating results stock-based compensation expenses (inclusive of related employer payroll taxes), the amortization of acquired intangible assets, and for 2011 it is also excluding a payment in lieu of a contingent obligation related to the acquisition of patent assets. Management uses these non-GAAP measures to evaluate the Company's financial results, and believes investors wish to exclude the effects of such items in comparing our financial performance with that of other companies. The adjustments to the Company's GAAP results are made with the intent of providing both management and investors a more complete understanding of the Company's underlying operational results, trends and performance. The presentation of additional information is not meant to be considered in isolation or as a substitute for or superior to financial results determined in accordance with GAAP.
Forward-Looking Statements
This news release and its attachments contain forward-looking statements within the meaning of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include statements regarding RPX's future financial performance as well as any statements regarding the Company's strategic and operational plans. The Company's actual results may differ materially from those anticipated in these forward-looking statements. Factors that may contribute to such differences include, among others, the Company's ability to maintain an adequate rate of growth, the impact of the current economic climate on the Company's business, the Company's ability to effectively manage its growth and changes in its executive team, and the Company's ability to attract new clients and retain existing clients. Forward-looking statements are often identified by the use of words such as, but not limited to, "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," "plan," "project," "seek," "should," "target," "will," "would," and similar expressions or variations intended to identify forward-looking statements. More information about potential factors that could affect the Company's business and financial results is contained in the Company's most recent annual report on Form 10-K, its quarterly reports on Form 10-Q, and the Company's other filings with the SEC. The Company does not intend, and undertakes no duty, to update any forward-looking statements to reflect future events or circumstances.
| RPX Corporation | ||||
| Condensed Consolidated Statements of Operations | ||||
| (in thousands, except per share data) | ||||
| (unaudited) | ||||
| Three Months Ended December 31, | Year Ended December 31, | |||
| 2012 | 2011 | 2012 | 2011 | |
| Revenue | $ 51,557 | $ 42,410 | $ 197,688 | $ 154,044 |
| Cost of revenue | 21,815 | 22,719 | 82,323 | 67,371 |
| Selling, general and administrative expenses | 13,687 | 12,128 | 53,590 | 40,593 |
| (Gain) on sale of patent assets, net | — | — | (177) | — |
| Operating income | 16,055 | 7,563 | 61,952 | 46,080 |
| Other income (expense), net | 25 | (78) | 117 | (723) |
| Income before provision for income taxes | 16,080 | 7,485 | 62,069 | 45,357 |
| Provision for income taxes | 5,982 | 566 | 23,112 | 16,225 |
| Net income | $ 10,098 | $ 6,919 | $ 38,957 | $ 29,132 |
| Net income available to common stockholders: | ||||
| Basic | $ 10,080 | $ 6,615 | $ 38,455 | $ 19,697 |
| Diluted | $ 10,080 | $ 6,633 | $ 38,474 | $ 20,310 |
| Net income per common share: | ||||
| Basic | $ 0.20 | $ 0.14 | $ 0.77 | $ 0.61 |
| Diluted | $ 0.19 | $ 0.13 | $ 0.74 | $ 0.57 |
| Weighted-average shares used in computing net income per common share: | ||||
| Basic | 50,824 | 46,920 | 49,766 | 32,032 |
| Diluted | 52,017 | 50,055 | 51,802 | 35,920 |
| RPX Corporation | ||
| Condensed Consolidated Balance Sheets | ||
| (in thousands) | ||
| (unaudited) | ||
| December 31, | ||
| 2012 | 2011 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 73,638 | $ 106,749 |
| Short-term investments | 126,092 | 126,976 |
| Restricted cash | — | 500 |
| Accounts receivable | 25,144 | 16,160 |
| Other receivables | 33,775 | — |
| Prepaid expenses and other current assets | 5,237 | 12,124 |
| Deferred tax assets | 7,658 | 5,192 |
| Total current assets | 271,544 | 267,701 |
| Patent assets, net | 199,314 | 163,352 |
| Property and equipment, net | 3,144 | 2,317 |
| Intangible assets, net | 3,226 | 1,837 |
| Goodwill | 16,460 | 1,675 |
| Restricted cash, less current portion | — | 147 |
| Deferred tax assets, less current portion | — | 300 |
| Other assets | 279 | 665 |
| Total assets | $ 493,967 | $ 437,994 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $ 568 | $ 821 |
| Accrued liabilities | 7,206 | 7,762 |
| Deferred revenue | 101,249 | 96,513 |
| Deferred payment obligations | 500 | 5,056 |
| Other current liabilities | 1,813 | 2,182 |
| Total current liabilities | 111,336 | 112,334 |
| Deferred revenue, less current portion | 3,122 | 11,762 |
| Deferred tax liabilities | 18,108 | 14,695 |
| Other liabilities | 1,142 | 119 |
| Total liabilities | 133,708 | 138,910 |
| Common stock | 5 | 5 |
| Additional paid-in capital | 281,530 | 259,315 |
| Retained earnings | 78,744 | 39,787 |
| Accumulated other comprehensive loss | (20) | (23) |
| Total stockholders' equity | 360,259 | 299,084 |
| Total liabilities and stockholders' equity | $ 493,967 | $ 437,994 |
| RPX Corporation | ||
| Condensed Consolidated Statements of Cash Flows | ||
| (in thousands) | ||
| (unaudited) | ||
| Year Ended December 31, | ||
| 2012 | 2011 | |
| Cash flows from operating activities | ||
| Net income | $ 38,957 | $ 29,132 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 83,137 | 63,446 |
| Stock-based compensation | 10,334 | 6,996 |
| Excess tax benefit from stock-based compensation | (8,574) | (2,302) |
| Imputed interest on deferred payment obligations | 94 | 727 |
| Gain on sale of patent assets | (177) | — |
| Amortization of premium on investments | 5,131 | 1,086 |
| Deferred taxes | 1,477 | 5,624 |
| Other | 12 | 8 |
| Changes in assets and liabilities: | ||
| Accounts receivable | (8,984) | (3,528) |
| Other receivables | (33,775) | — |
| Prepaid expenses and other assets | 8,667 | (12,085) |
| Accounts payable | (253) | 332 |
| Accrued and other liabilities | (711) | 5,198 |
| Deferred revenue | (3,958) | 25,714 |
| Net cash provided by operating activities | 91,377 | 120,348 |
| Cash flows from investing activities | ||
| Purchases of investments classified as available-for-sale | (185,582) | (202,430) |
| Maturities and sale of investments classified as available-for-sale | 188,026 | 78,246 |
| Business acquisition | (45,765) | (3,345) |
| Decrease in restricted cash | 647 | 73 |
| Purchases of intangible assets | (64) | (112) |
| Purchases of property and equipment | (1,726) | (1,971) |
| Acquisitions of patent assets | (87,366) | (101,170) |
| Proceeds from sale of patent assets | 200 | 80 |
| Net cash used in investing activities | (131,630) | (230,629) |
| Cash flows from financing activities | ||
| Repayments of principal on deferred payment obligations | (5,150) | (19,254) |
| Proceeds from other obligations | 500 | — |
| Proceeds from issuance of common stock in initial public offering, net of issuance costs | — | 157,478 |
| Proceeds from issuance of common stock in follow-on offering, net of issuance costs | — | 26,855 |
| Proceeds from exercise of stock options and other common stock issuances | 3,218 | 2,993 |
| Excess tax benefit from stock-based compensation | 8,574 | 2,302 |
| Net cash provided by financing activities | 7,142 | 170,374 |
| Net increase (decrease) in cash and cash equivalents | (33,111) | 60,093 |
| Cash and cash equivalents at beginning of period | 106,749 | 46,656 |
| Cash and cash equivalents at end of period | $ 73,638 | $ 106,749 |
| RPX Corporation | ||||
| Reconciliation of Pro Forma Net Income Per Share | ||||
| (in thousands, except per share data) | ||||
| (unaudited) | ||||
| Three Months Ended December 31, | Year Ended December 31, | |||
| 2012 | 2011 | 2012 | 2011 | |
| Net income | $ 10,098 | $ 6,919 | $ 38,957 | $ 29,132 |
| Pro forma net income per share: | ||||
| Basic | $ 0.20 | $ 0.14 | $ 0.77 | $ 0.66 |
| Diluted | $ 0.19 | $ 0.13 | $ 0.74 | $ 0.60 |
| Shares used in computing pro forma net income per share: | ||||
| Basic: | ||||
| Basic weighted-average common shares | 50,824 | 46,920 | 49,766 | 32,032 |
| Less: Conversion of redeemable convertible preferred shares | — | — | — | (16,960) |
| Add: Assumed conversion of redeemable convertible preferred shares | — | — | — | 26,230 |
| Add: Restricted stock | 91 | 2,158 | 649 | 3,114 |
| Shares used in computing pro forma basic net income per share | 50,915 | 49,078 | 50,415 | 44,416 |
| Diluted: | ||||
| Diluted weighted-average common shares | 52,017 | 50,055 | 51,802 | 35,920 |
| Less: Conversion of redeemable convertible preferred shares | — | — | — | (16,960) |
| Add: Assumed conversion of redeemable convertible preferred shares | — | — | — | 26,230 |
| Add: Restricted stock | 91 | 2,158 | 649 | 3,114 |
| Shares used in computing pro forma diluted net income per share | 52,108 | 52,213 | 52,451 | 48,304 |
| RPX Corporation | ||||
| Reconciliation of GAAP to Pro Forma Non-GAAP Net Income Per Share | ||||
| (in thousands, except per share data) | ||||
| (unaudited) | ||||
| Three Months Ended December 31, | Year Ended December 31, | |||
| 2012 | 2011 | 2012 | 2011 | |
| Net income | $ 10,098 | $ 6,919 | $ 38,957 | $ 29,132 |
| Stock-based compensation[1] | 2,873 | 2,166 | 10,683 | 7,015 |
| Amortization of acquired intangible assets[2] | 360 | 146 | 1,192 | 292 |
| Payment in lieu of contingent obligation[3] | — | 4,000 | — | 4,000 |
| Income tax adjustments[4] | (1,061) | (1,944) | (3,750) | (3,356) |
| Non-GAAP net income | $ 12,270 | $ 11,287 | $ 47,082 | $ 37,083 |
| Pro forma non-GAAP net income per share: | ||||
| Basic | $ 0.24 | $ 0.23 | $ 0.93 | $ 0.83 |
| Diluted | $ 0.24 | $ 0.22 | $ 0.90 | $ 0.77 |
| Pro forma weighted-average shares: | ||||
| Basic | 50,915 | 49,078 | 50,415 | 44,416 |
| Diluted | 52,108 | 52,213 | 52,451 | 48,304 |
| RPX Corporation | ||||||||
| Reconciliation of GAAP to Non-GAAP Cost of Revenue | ||||||||
| (in thousands) | ||||||||
| (unaudited) | ||||||||
| Three Months Ended December 31, | Year Ended December 31, | |||||||
| 2012 | 2011 | 2012 | 2011 | |||||
| Cost of revenue | $ 21,815 | $ 22,719 | $ 82,323 | $ 67,371 | ||||
| Payment in lieu of contingent obligation[3] | — | (4,000) | — | (4,000) | ||||
| Amortization of acquired intangible assets[2] | (55) | (51) | (223) | (104) | ||||
| Non-GAAP cost of revenue | $ 21,760 | $ 18,668 | $ 82,100 | $ 63,267 | ||||
| RPX Corporation | ||||||||
| Reconciliation of GAAP to Non-GAAP Selling, General and Administrative Expenses | ||||||||
| (in thousands) | ||||||||
| (unaudited) | ||||||||
| Three Months Ended December 31, | Year Ended December 31, | |||||||
| 2012 | 2011 | 2012 | 2011 | |||||
| Selling, general and administrative expenses | $ 13,687 | $ 12,128 | $ 53,590 | $ 40,593 | ||||
| Stock-based compensation[1] | (2,873) | (2,166) | (10,683) | (7,015) | ||||
| Amortization of acquired intangible assets[2] | (305) | (95) | (969) | (188) | ||||
| Non-GAAP selling, general and administrative expenses | $ 10,509 | $ 9,867 | $ 41,938 | $ 33,390 | ||||
| [1] RPX excludes stock-based compensation and related employer payroll taxes from its non-GAAP financial measures. | ||||||||
| [2] RPX excludes amortization expense related to intangible assets (other than patents) acquired in conjunction with the acquisition of businesses from its non-GAAP financial measures. | ||||||||
| [3] In 2008, RPX entered into an agreement to purchase patent assets with an unaffiliated third party which stipulated that RPX make a one-time payment of $5.0 million in the event RPX earned $170.0 million of subscription revenue in any calendar year. In 2011, RPX agreed to pay $4.0 million in lieu of the $5.0 million contingent payment. | ||||||||
| [4] Amount reflects income taxes associated with the above noted non-GAAP exclusions. | ||||||||
| RPX Corporation | ||
| Additional Metrics | ||
| ($ in thousands) | ||
| (unaudited) | ||
| As of and for the Three Months Ended December 31, | ||
| Operating Metrics | 2012 | 2011 |
| Number of clients | 140 | 112 |
| Net additions | 12 | 9 |
| Trailing four quarters | 28 | 40 |
| Gross acquisition spend | $ 104,360 | $ 28,730 |
| Trailing four quarters | $ 251,800 | $ 103,796 |
| Net acquisition spend | $ 23,160 | $ 28,730 |
| Trailing four quarters | $ 116,370 | $ 99,171 |
| Full time equivalent headcount | 125 | 110 |
| As of and for the Year Ended December 31, | ||
| Financial Metrics | 2012 | 2011 |
| Subscription revenue[1] | $ 185,609 | $ 150,721 |
| Advisory fees | 2,000 | — |
| Other revenue | 10,079 | 3,323 |
| Revenue | $ 197,688 | $ 154,044 |
| Cash, cash equivalents and short-term investments | $ 199,730 | $ 233,725 |
| Deferred revenue, current and noncurrent | $ 104,371 | $ 108,275 |
| [1] Subscription revenue is comprised of revenue generated from membership subscription services and premiums earned from insurance policies. | ||
CONTACT: Investor Relations
JoAnn Horne
Market Street Partners
+1-415-445-3233
ir@rpxcorp.com
Media Relations
Kaustuva Das
RPX Corporation
+1-415-529-3105
media@rpxcorp.com